AU2012233590B2 - Agent for improving or maintaining QOL - Google Patents

Agent for improving or maintaining QOL Download PDF

Info

Publication number
AU2012233590B2
AU2012233590B2 AU2012233590A AU2012233590A AU2012233590B2 AU 2012233590 B2 AU2012233590 B2 AU 2012233590B2 AU 2012233590 A AU2012233590 A AU 2012233590A AU 2012233590 A AU2012233590 A AU 2012233590A AU 2012233590 B2 AU2012233590 B2 AU 2012233590B2
Authority
AU
Australia
Prior art keywords
improving
sustaining
qol
agent
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012233590A
Other languages
English (en)
Other versions
AU2012233590A1 (en
AU2012233590A2 (en
Inventor
Noriyuki Kouda
Takao Saito
Shoji Shinkai
Masamichi Toba
Mina TSUBOUCHI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU2012233590A1 publication Critical patent/AU2012233590A1/en
Publication of AU2012233590A2 publication Critical patent/AU2012233590A2/en
Application granted granted Critical
Publication of AU2012233590B2 publication Critical patent/AU2012233590B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
AU2012233590A 2011-03-31 2012-03-28 Agent for improving or maintaining QOL Active AU2012233590B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011080814 2011-03-31
JP2011-080814 2011-03-31
PCT/JP2012/058145 WO2012133533A1 (ja) 2011-03-31 2012-03-28 Ｑｏｌ改善又は持続剤

Publications (3)

Publication Number Publication Date
AU2012233590A1 AU2012233590A1 (en) 2013-10-10
AU2012233590A2 AU2012233590A2 (en) 2014-05-08
AU2012233590B2 true AU2012233590B2 (en) 2017-06-08

Family

ID=46931242

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012233590A Active AU2012233590B2 (en) 2011-03-31 2012-03-28 Agent for improving or maintaining QOL

Country Status (12)

Country Link
US (2) US9623054B2 (https=)
EP (1) EP2692349B1 (https=)
JP (2) JP6061842B2 (https=)
KR (1) KR101878525B1 (https=)
CN (1) CN103458905A (https=)
AU (1) AU2012233590B2 (https=)
CA (1) CA2831554C (https=)
ES (1) ES2617989T3 (https=)
PH (1) PH12013501951A1 (https=)
SG (3) SG193508A1 (https=)
TW (1) TWI642363B (https=)
WO (1) WO2012133533A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108495558A (zh) * 2016-04-20 2018-09-04 株式会社明治 疲劳感改善用发酵乳
TWI583388B (zh) 2016-08-24 2017-05-21 國立體育大學 胚芽乳酸桿菌用於製備改善運動表現及降低肌肉疲勞之益生菌組合物之用途
US20220233613A1 (en) * 2019-06-03 2022-07-28 Asahi Group Holdings, Ltd. Walking ability improver
JP7593740B2 (ja) * 2020-03-02 2024-12-03 株式会社明治 睡眠の質改善用組成物、全体的健康感改善用組成物および活力向上用組成物
JP7703165B2 (ja) * 2020-07-27 2025-07-07 独立行政法人国立病院機構 Ｑｏｌ改善剤
TW202442251A (zh) 2023-04-12 2024-11-01 葡萄王生技股份有限公司 抗疲勞乳酸菌組成物及其用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1661983A1 (en) * 2003-08-21 2006-05-31 Otsuka Pharmaceutical Co., Ltd. Lactic acid bacteria having mucosal immunopotentiation effect
EP1854363A1 (en) * 2005-02-23 2007-11-14 Otsuka Pharmaceutical Co., Ltd. Fermented tea beverage and tea beverage
JP2010222329A (ja) * 2009-03-25 2010-10-07 Otsuka Pharmaceut Co Ltd 抗鳥インフルエンザウイルス抗体の産生促進剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060028426A (ko) * 2003-06-24 2006-03-29 오츠카 세이야쿠 가부시키가이샤 혈청 요산치 감소용 조성물
US8182849B2 (en) 2005-02-23 2012-05-22 Otsuka Pharmaceutical Co., Ltd. Fermented tea beverage and tea beverage

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1661983A1 (en) * 2003-08-21 2006-05-31 Otsuka Pharmaceutical Co., Ltd. Lactic acid bacteria having mucosal immunopotentiation effect
EP1854363A1 (en) * 2005-02-23 2007-11-14 Otsuka Pharmaceutical Co., Ltd. Fermented tea beverage and tea beverage
JP2010222329A (ja) * 2009-03-25 2010-10-07 Otsuka Pharmaceut Co Ltd 抗鳥インフルエンザウイルス抗体の産生促進剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALAN C LOGAN ET AL, "Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value", MEDICAL HYPOTHESES, (20030601), vol. 60, no. 6, doi:10.1016/S0306-9877(03)00096-3, ISSN 0306-9877, pages 915 - 923 *

Also Published As

Publication number Publication date
SG193508A1 (en) 2013-10-30
WO2012133533A1 (ja) 2012-10-04
PH12013501951A1 (en) 2019-07-03
SG10201912606QA (en) 2020-02-27
CA2831554C (en) 2021-08-03
KR20140026433A (ko) 2014-03-05
ES2617989T3 (es) 2017-06-20
CA2831554A1 (en) 2012-10-04
US20170216379A1 (en) 2017-08-03
CN103458905A (zh) 2013-12-18
SG10201602487SA (en) 2016-05-30
AU2012233590A1 (en) 2013-10-10
US20140017217A1 (en) 2014-01-16
US9623054B2 (en) 2017-04-18
EP2692349A4 (en) 2014-11-05
JP6261688B2 (ja) 2018-01-17
JP2017019841A (ja) 2017-01-26
KR101878525B1 (ko) 2018-07-13
JPWO2012133533A1 (ja) 2014-07-28
TW201244647A (en) 2012-11-16
AU2012233590A2 (en) 2014-05-08
US10369177B2 (en) 2019-08-06
EP2692349B1 (en) 2016-12-28
TWI642363B (zh) 2018-12-01
EP2692349A1 (en) 2014-02-05
JP6061842B2 (ja) 2017-01-18

Similar Documents

Publication Publication Date Title
US10369177B2 (en) Agent for improving or maintaining QOL
KR100908254B1 (ko) 항알레르기용 조성물
Coman et al. Effect of buckwheat flour and oat bran on growth and cell viability of the probiotic strains Lactobacillus rhamnosus IMC 501®, Lactobacillus paracasei IMC 502® and their combination SYNBIO®, in synbiotic fermented milk
CN111935995A (zh) 营养组合物以及使用了该营养组合物的饮食品组合物和配方奶粉
US20190126075A1 (en) Food and drink product containing poorly digestible compound and colonic-hydrogen-gas producing agent
KR101823459B1 (ko) 헬리코박터 파이로리에 대한 항균활성과 응집력을 갖는 락토바실러스 파라카제이 hp7 및 이를 유효성분으로 함유하는 제품
US20220022516A1 (en) Composition for Suppressing Norovirus Infection
US8980289B2 (en) Intestine immunomodulator
TW202207957A (zh) 具有優異的耐酸性和耐膽汁性且對血脂異常症具有預防或治療效果的新型短雙歧桿菌idcc 4401菌株及其死菌體id-bbr4401
WO2022196488A1 (ja) Ｑｏｌを改善するための組成物
HK1189816B (en) Agent for improving or maintaining qol
HK1189816A (en) Agent for improving or maintaining qol
JP2007126399A (ja) グルタチオン増加用組成物
AU2020289102B2 (en) Walking ability improver
JP2009254236A (ja) 新規乳酸菌並びに新規乳酸菌を利用した飲食品及び免疫賦活剤
KR100854816B1 (ko) 항알레르기용 조성물
WO2025197951A1 (ja) 免疫細胞の増殖の促進のための組成物
CN120118785A (zh) 用于促进皮肤健康的凝结魏茨曼氏菌
HK1090289B (en) Antiallergic composition

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 18 SEP 2013

FGA Letters patent sealed or granted (standard patent)